Latest Breaking News On - Stephan christgau - Page 2 : comparemela.com

Scenic Biotech scores $31M to take aim at genetic modifiers for cancer & rare disease

Targeting mutations isn’t the only way to treat genetically driven diseases. Scenic Biotech is developing molecules to target genes that suppress disease, and it has raised $31 million to advance its pipeline of potential therapies for cancer and rare diseases.

Roche genentechStephan christgauOrphayzme neimannGilead sciencesLeiden university medical centerOxford science enterprisesNetherlands cancer instituteOxford universityScenic biotechLeiden university medicalForty sevenTrillium therapeuticsNiemann pickKeir venturesInkef capitalBiogeneration ventures

Morningside Launches Inflammatory-focused Adiso, Scenic Scores $31M for Rare Diseases

Morningside Ventures launched a new biotech company called Adiso Therapeutics, and thriving startup Scenic Biotech scooped up €28 million ($31 million) in funding.

United statesStephan christgauScott megaffinDrug administrationNetherlands cancer instituteOxford universityBoston financial districtAdiso therapeuticsScenic biotechMorningside venturesGenerate biomedicsRevir therapeuticsAdiso therapeuticFast track designationKeir venturesVesalius biocapital

Scenic Biotech Raises $31 Million to Advance Pipeline of Genetic Modifiers in Cancer and Rare Diseases

Scenic Biotech Raises $31 Million to Advance Pipeline of Genetic Modifiers in Cancer and Rare Diseases
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Stephan christgauOscar izeboudMichael wackerStephane verdoodOxford science enterprisesRoche groupScenic biotechKeir venturesVesalius biocapitalInkef capitalBiogeneration ventures

University of Copenhagen: UCPH establishes investment company to boost entrepreneurship activities

The University of Copenhagen (UCPH) has established a limited company with the main aim of investing in the University’s own spin-out companies. It is the first time that a Danish university establishes an investment company of this kind.UCPH Venture

Snorri sturlusonStephan christgauSusanne kureKim brinckmannAlexander schrHenrik wegenerUniversity of copenhagenEuropean investment fundDanish growth fundNovo holdingsRector henrik wegenerKeir venturesSwedish actAlternative investmentOld norsePrivate equity administrators

Eir Ventures Partners Closes Life Science Venture Fund, at EUR122M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Vastra gotalands lanKarolinska institutetStephan christgauSortina pharmaMagnus perssonGothenburg universityKarolinska instituteCopenhagen universityUniversity of lundEuropean investment fundLund universitySustainable development umbrella fundEuropean unionNovo holdingsAarhus universityEir ventures partners